We are live on
!
Find out more
ACM
Apex Capital Management Portfolio holdings
AUM
$4.54B
1-Year Est. Return
1.74%
This Fund
S&P 500
This Quarter
Est. Return
+7.31%
1 Year Est. Return
+1.74%
3 Year Est. Return
+80.63%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.75B
AUM Growth
+$436M
(+13%)
Cap. Flow
+$286M
Cap. Flow
% of AUM
7.63%
Top 10 Holdings %
Top 10 Hldgs %
19.71%
Holding
267
New
24
Increased
137
Reduced
57
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Universal Health Services
UHS
|
+$69.6M |
| 2 |
KS
KapStone Paper and Pack Corp.
KS
|
+$47.7M |
| 3 |
HDS
HD Supply Holdings, Inc.
HDS
|
+$38.4M |
| 4 |
VRNT
Verint Systems
VRNT
|
+$31.2M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$30.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$59.3M |
| 2 |
Visteon
VC
|
+$53.5M |
| 3 |
Affiliated Managers Group
AMG
|
+$42.3M |
| 4 |
Helmerich & Payne
HP
|
+$41.8M |
| 5 |
Cullen/Frost Bankers
CFR
|
+$33.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 22.21% |
| 2 | Consumer Discretionary | 19.42% |
| 3 | Healthcare | 16.62% |
| 4 | Technology | 13.68% |
| 5 | Financials | 4.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
COV
201
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $598K | 0.02% |
5,846
-35,265
| -86% | -$3.38M |
|
202
Deere & Co
DE
$163B
| $580K | 0.02% |
6,559
-40
| -0.6% | -$3.46K |
|
203
PIMCO Corporate & Income Opportunity Fund
PTY
$2.49B
| $576K | 0.02% |
+36,232
| New | +$643K |
|
204
Colgate-Palmolive
CL
$71.6B
| $567K | 0.02% |
8,200
| – | – |
|
|
WBA
205
DELISTED
Walgreens Boots Alliance
WBA
| $565K | 0.02% |
7,418
| – | – |
|
206
Amgen
AMGN
$204B
| $564K | 0.02% |
3,540
| – | – |
|
207
Check Point Software Technologies
CHKP
$12.6B
| $561K | 0.01% |
+7,145
| New | +$531K |
|
208
ExxonMobil
XOM
$643B
| $554K | 0.01% |
5,988
+1
| +0% | +$93 |
|
209
LyondellBasell Industries
LYB
$19.6B
| $549K | 0.01% |
6,911
+1,086
| +19% | +$94.2K |
|
210
Cisco
CSCO
$457B
| $539K | 0.01% |
19,395
+210
| +1% | +$5.42K |
|
211
Home Depot
HD
$339B
| $538K | 0.01% |
5,125
| – | – |
|
212
Sony
SONY
$133B
| $526K | 0.01% |
+128,500
| New | +$507K |
|
213
Boeing
BA
$185B
| $525K | 0.01% |
4,040
+35
| +0.9% | +$4.44K |
|
214
CGI
GIB
$15.1B
| $518K | 0.01% |
13,575
| – | – |
|
215
Novartis
NVS
$292B
| $512K | 0.01% |
6,171
+1,651
| +37% | +$137K |
|
|
AGU
216
DELISTED
Agrium
AGU
| $510K | 0.01% |
5,384
+1,184
| +28% | +$111K |
|
217
Teva Pharmaceuticals
TEVA
$40.2B
| $504K | 0.01% |
8,765
-3,845
| -30% | -$214K |
|
218
VF Corp
VFC
$5.87B
| $497K | 0.01% |
7,046
| – | – |
|
219
Walmart Inc
WMT
$881B
| $497K | 0.01% |
17,361
+177
| +1% | +$4.78K |
|
220
Broadcom
AVGO
$1.87T
| $481K | 0.01% |
47,840
| – | – |
|
221
Amazon
AMZN
$3.06T
| $480K | 0.01% |
30,940
| – | – |
|
222
Sun Life Financial
SLF
$45.7B
| $476K | 0.01% |
13,200
| – | – |
|
223
British American Tobacco
BTI
$128B
| $474K | 0.01% |
8,800
| – | – |
|
224
AB InBev
BUD
$166B
| $473K | 0.01% |
4,209
+1,430
| +51% | +$158K |
|
|
NVO
225
Novo Nordisk
NVO
$208B
| $450K | 0.01% |
21,250
| – | – |
|
Similar funds
BKBG
CAM
VRS
FMA
KG
NPIT
AIA
EIM
Apex Capital Management's Q4 2014 Portfolio in Review
As of Q4 2014, Apex Capital Management held 267 positions worth $3.75B, up 13% from $3.32B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Apex Capital Management deployed $286M of net new capital in Q4 2014, opening 24 new positions and adding to 137 existing holdings. Its largest new stake was Universal Health Services: 662,924 shares worth $73.8M.
By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Visteon, an estimated $53.5M trimmed.
- Apex Capital Management's largest Q4 2014 buy was Universal Health Services: 662,924 shares worth $73.8M.
- Apex Capital Management added most to Verint Systems in Q4 2014, an estimated $31.2M increase.
- Apex Capital Management's biggest Q4 2014 reduction was Visteon, cutting an estimated $53.5M.
- Apex Capital Management fully exited SALIX PHARMACEUTICALS LTD DEL in Q4 2014, selling an estimated $59.3M.
- Apex Capital Management's ten largest holdings make up 20% of its $3.75B portfolio in Q4 2014.
- Apex Capital Management opened 24 new positions and closed 17 in Q4 2014.
- Apex Capital Management's portfolio value rose 13% quarter-over-quarter to $3.75B.
Based on Apex Capital Management's 13F filing for Q4 2014, filed 20 Jan 2015.